Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.
about
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver diseaseRole of stem cells during diabetic liver injuryComorbidities and Metabolic Derangement of NAFLDThe role of fatty acids in insulin resistanceUse of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerationsFinding needles in a haystack: application of network analysis and target enrichment studies for the identification of potential anti-diabetic phytochemicalsEffects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes.Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.The Role of Insulin Therapy in Correcting Hepcidin Levels in Patients with Type 2 Diabetes Mellitus.Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 AdultsAssociated liver enzymes with hyperlipidemic profile in type 2 diabetes patients.Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese populationLiver resection and metabolic disorders: an undescribed mechanism leading to postoperative mortality.Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial.Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study.Drug-related problems in type 2 diabetes mellitus patients with dyslipidemiaCardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic controlIdentifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls.The role of hepatic lipids in hepatic insulin resistance and type 2 diabetesLoss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformationEffect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial.Anti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice.Diabetes and Hepatitis C: A Two-Way Association.No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLDNoninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?Associations with fracture in patients with diabetes: a nested case-control study.Protective effect of aqueous extract of Feronia elephantum correa leaves on thioacetamide induced liver necrosis in diabetic ratsIncreased risk of CKD among type 2 diabetics with nonalcoholic fatty liver diseaseGlucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults.Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.Cryptolepine, an indoloquinoline alkaloid, in the management of diabetes mellitus and its associated complicationsLiver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and managementLong-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight lossAssociation between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal eventsHepatic transcriptome implications for palm fruit juice deterrence of type 2 diabetes mellitus in young male Nile rats.The Cause-and-Effect Relationship Between Type 2 Diabetes Mellitus and Clinically Overt Cryptogenic Cirrhosis: A Matter That Must Be Seriously Revised.
P2860
Q24655078-C3ECA595-8DFE-45F2-BA1E-6E1D37F073E3Q26773551-50FBA82C-F17D-4D88-B74F-50231B315C61Q26777147-DC703773-0F55-4E71-8226-9CA4963B53DBQ26785440-FB3E69E4-772E-4BA6-8837-372C9236647AQ28072205-94E20030-689D-4C8E-8C48-BEDD2B08FA60Q28544976-9B87D4A6-1889-41B2-AE8A-3B41A5EA4DA2Q33612248-D5A5E724-2DC7-46AB-9D2E-5904EA5B1AB9Q33735381-6A9B9330-0053-44D3-8BB3-0A35C93C0981Q33736818-E30ED819-AC58-4ADA-9A50-9EF0644A0AE8Q33828131-47BBC4AC-6C7E-401F-8ADF-AF6DC35D7388Q33859074-0E46492B-E392-4EE5-A557-6D74162B5A6BQ33875821-2FCA5106-E3E8-47F5-8C9C-214CFFB056D9Q34029281-C67FAE3A-32DE-4946-9B5F-246DA14FAAC7Q34360938-495A8A98-EDC8-478B-A2E7-637B285FB769Q34366984-6A168B46-198E-4B6F-808A-ED9A71F9F9D2Q34466433-7E16D503-0332-465E-9D63-8F817BC468F9Q34536946-780F03CB-8D94-4209-B05E-E4441534E1D2Q35068358-BC23DA7A-0DDA-481F-9CF8-AEA6AD4EF7D8Q35090471-BD79C20E-2445-48FB-8BD8-D402FF0F3811Q35292109-FC851132-0CCD-492E-84EC-015E5A9C0E60Q35811523-3DEBA8E2-7050-4AE1-8035-339D9B0E38DBQ35835250-96DDBBDC-160D-4BF1-843D-C70DF2E9E145Q35865699-14B7287C-44DF-4628-A430-2FF8E3995058Q35895011-E0E61C5C-5D0D-4935-9930-72696DA8300FQ36056076-788AB636-648B-46B3-AE69-3D57F0CE9AB4Q36063593-62C8FE9C-D3D8-4B3F-9B16-2B4E249A4B60Q36134426-DFC77E80-6B4C-4819-AD32-99E6DA33EAA7Q36531654-1F3DC560-B77A-482E-B741-D95A30F127D6Q36602825-946BAB91-CF96-4728-BB5E-B57EDD49D45DQ36719949-FA2D7678-0CB5-45EB-84D8-3423D17E815FQ36796750-B9818C75-A179-4A48-A7A6-F9E793F3671CQ36980627-F92B2A9D-6175-4F65-AC67-0E27E1B1D22FQ36983522-452E3D9E-0771-46CD-954B-067265E9962AQ37037308-C2337F64-2B69-4235-B02E-D39744B1C7A9Q37052420-E0EEC5F1-2D80-4F2E-A148-28E2AB5723A4Q37122216-3CA63418-5057-418E-BDEC-4CF7EB15AA60Q37277970-3BDF0F42-1CA4-4A56-A9FB-62940399C3CCQ37282849-434CD473-9363-462E-A09D-4F84C0D34CE4Q37358926-3C032907-405E-4C8D-9D97-0FD82A5D2D23Q37387546-D67D4D23-0622-40E2-8C02-B561F121E321
P2860
Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Spectrum of liver disease in t ...... th diabetes and liver disease.
@en
type
label
Spectrum of liver disease in t ...... th diabetes and liver disease.
@en
prefLabel
Spectrum of liver disease in t ...... th diabetes and liver disease.
@en
P2093
P356
P1433
P1476
Spectrum of liver disease in t ...... th diabetes and liver disease.
@en
P2093
Anthony Dalpiaz
Keith G Tolman
Meng H Tan
Vivian Fonseca
P304
P356
10.2337/DC06-1539
P407
P577
2007-03-01T00:00:00Z